Osanetant

From Self-sufficiency
Jump to: navigation, search
Osanetant
220px
Systematic (IUPAC) name
N-(1-{3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl}-4-phenylpiperidin-4-yl]-N-methylacetamide
Identifiers
CAS Number 160492-56-8
ATC code none
PubChem CID 219077
Chemical data
Formula C35H41Cl2N3O2
Molar mass 606.625 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Osanetant (SR-142,801) is a neurokinin 3 receptor antagonist developed by Sanofi-Synthélabo, which is being researched for the treatment of schizophrenia.[1] It was the first non-peptide NK3 antagonist developed in the mid-1990s,[2] and has still not made it to market, although clinical trials are continuing.[3] Another potential application for osanetant is in the treatment of drug addiction, as it has been found to block the effects of cocaine in animal models.[4][5]

References

  1. ↑ Kamali F. Osanetant Sanofi-Synthélabo. Current Opinion in Investigational Drugs. 2001 Jul;2(7):950-6. PMID 11757797
  2. ↑ Emonds-Alt X, Bichon D, Ducoux JP, Heaulme M, Miloux B, Poncelet M, Proietto V, Van Broeck D, Vilain P, Neliat G, et al. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sciences. 1995;56(1):PL27-32. PMID 7830490
  3. ↑ Quartara L, Altamura M. Tachykinin receptors antagonists: from research to clinic. Current Drug Targets. 2006 Aug;7(8):975-92. PMID 16918326
  4. ↑ De Souza Silva MA, Mello EL Jr, Müller CP, Jocham G, Maior RS, Huston JP, Tomaz C, Barros M. The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys. European Journal of Pharmacology. 2006 May 1;536(3):269-78. PMID 16603151
  5. ↑ Jocham G, Lezoch K, Müller CP, Kart-Teke E, Huston JP, de Souza Silva MA. Neurokinin receptor antagonism attenuates cocaine's behavioural activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core. European Journal of Neuroscience. 2006 Sep;24(6):1721-32. PMID 17004936


Stub icon This pharmacology-related article is a stub. You can help ssf by expanding it.
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Osanetant&oldid=23445"